logo
MyVoice: Views of our readers 2nd Aug 2025

MyVoice: Views of our readers 2nd Aug 2025

Hans India2 days ago
MLAs defections: SC directions praiseworthy
The Supreme Court ordering the speaker of the Telangana Legislative Assembly to take decision on the ten MLAs who are facing charges of defection within three months is praiseworthy. The speaker has been taking time longer than it should be to decide the matter, subverting the spirit of the anti-defection law.
Though there is no mention of time limit in rule books for speakers to take a call on defections, the inordinate delay makes a mockery of well laid down democratic norms. It's good that the apex court has set the record straight and hopefully the speaker will act per the court ruling.
Dr DVG Sankara Rao, Vizianagaram
Put a permanent stop to defections
The speakers of Parliament and that of the State legislative bodies have often been found undermining democratic values when it comes to defections by elected people's representatives. Indian democracy has always been subverted by opportunistic politicians, who derive tacit support from speakers, who misuse their constitutional authority in taking decisions vis-à-vis the detectors. It is now for the Parliament to 'listen' to the sentiments expressed by the Supreme Court in this regard and set the record straight.
But none of the political parties would want to close doors to their pursuit of power, by hook or crook. And for them 'defection' is the biggest weapon even if it means subverting democracy! The Supreme Court can't order the speakers to take decisions within a stipulated time frame. It is for the Parliament to reconcile and bring in legislation to permanently settle the issue, so that the menace of defections is stopped once and for all.
Govardhana Myneedu, Vijayawada
Historic ruling by the Supreme Court
SC giving the Telangana Legislative Assembly speaker three months to decide on the defection of 10 BRS employees to Congress is a historical decision. However, it raises a crucial question: why not work out a robust constitutional provision to prevent defections altogether? In instances where MLAs switch loyalties after winning elections, a clear provision could mandate resignation from the incumbent party before joining another.
This would uphold democratic values and prevent the erosion of public trust. Notably, many political leaders, including K Chandrasekhar Rao, K T Rama Rao, and N Chandrababu Naidu have encouraged such defections, undermining the integrity of the electoral process. In this context, the Supreme Court's role becomes pivotal in protecting democratic principles and ensuring accountability. A strong constitutional provision would help prevent future incidents and restore faith in the system. The judiciary's proactive stance is crucial in upholding the nation's democratic fabric.
Dr. Venkat Yadav Avula, MASS Hyderabad
Calling Trump's tariff bluff
In an increasingly fractious world order, the U.S. fired another salvo in its trade war targeting India with a hefty tariff on exports effective from August 1, besides additional penalties for buying Russian oil and arms. This only goes to show that US President Donald Trump has been a vitriolic opportunity offender, who cannot be fully relied upon. However, India's response to Trump's provocations has been measured and non-combative by saying that India will protect the interests of its farmers and MSMEs. Apparently, Trump must understand that like earlier, India is not a soft state now with deep economic resilience, vast domestic absorption capacity, therefore, there can be no giving in to his pressure tactics.
Despite Trump describing closeness of India and Russia as 'dead economies', it is imperative that India refrain from reacting in a knee-jerk manner by keeping calm while trying to explore fast-track deals with the EU and other destinations more or less on the deals signed with the UK. India must adopt a cautious approach while at the same time remaining firm in its dealings that sends a strong message to Trump to agree to even terms in trade policy because his likes and dislikes of BRICS and global South is not going to help America in any manner in the long term both in trade and foreign policy matters with India.
K R Srinivasan, Secunderabad-3
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US tariffs should not be cause for disengaging from trade talks, blocs
US tariffs should not be cause for disengaging from trade talks, blocs

Business Standard

time23 minutes ago

  • Business Standard

US tariffs should not be cause for disengaging from trade talks, blocs

The fundamental challenge for the Indian economy is to increase productivity and competitiveness premium Business Standard Editorial Comment Mumbai Listen to This Article The tariff rate of 25 per cent, which United States (US) President Donald Trump has decided will be applied to Indian exports to the US, may not, eventually, be the final rate. It may effectively wind up being higher if he carries out his threat to add a surcharge related to India's increasing purchases of Russian oil. It may be lower if New Delhi's negotiators pull some sort of a broader deal together. It is also worth remembering that there will be multiple exceptions to this headline tariff rate. Some goods that compose a large part of India-US trade —

Following are the top foreign stories at 2100 hours
Following are the top foreign stories at 2100 hours

News18

time32 minutes ago

  • News18

Following are the top foreign stories at 2100 hours

FGN6 BANGLA-HASINA ****Bangladesh tribunal commences trial of deposed PM Hasina over crimes against humanity Dhaka: Bangladesh's International Crimes Tribunal (ICT) on Sunday commenced the trial of deposed Prime Minister Sheikh Hasina in absentia over crimes against humanity related to the violent suppression of the 2024 student-led protests.**** FGN17 BANGLA-RALLIES ****B'desh: BNP's student wing, NCP hold rallies ahead of July Uprising anniversary Dhaka: Activists of the National Citizen Party and the BNP's student wing held separate rallies in Bangladesh on Sunday ahead of the first anniversary of the July Uprising that toppled the Sheikh Hasina-led government on August 5 last year.**** FGN9 PAK-IRAN-NUCLEAR ****Pakistan supports Iran's right to develop nuclear capability for peaceful purposes Islamabad: Pakistan on Sunday supported Iran's right to develop nuclear capability for peaceful purposes, as the two sides signed several agreements to expand cooperation in multiple fields.**** FGN8 PAK-IRAN-TRADE ****Pakistan: Iran decide to increase bilateral trade to USD 8 billion annually Islamabad: Pakistan and Iran agreed on Sunday to increase bilateral trade to USD 8 billion annually, taking advantage of their geography and the 'discount of distance," as trade ministers from the two countries held discussions to deepen economic and political ties.**** FGN14 US-INDIANS-ACCIDENT ****Four senior Indian-origin persons killed in car crash in West Virginia New York: In a tragic incident, four senior Indian-origin persons were killed in a car crash in West Virginia, authorities said on Sunday.

How Trump tariffs could impact Indian pharma's $8.7 bn dream run
How Trump tariffs could impact Indian pharma's $8.7 bn dream run

India Today

time39 minutes ago

  • India Today

How Trump tariffs could impact Indian pharma's $8.7 bn dream run

For long, the high-value US market has driven the growth of the storied Indian generic drugs industry, where companies like Cipla, Sun Pharma and Dr Reddy's Laboratories, among others, have successfully challenged hundreds of off-patent drugs in the US and established a soaring business FY24, India exported $8.7 billion (Rs 76,113 crore) worth of pharma products to the US, which comprises over 11 per cent of India's total merchandise exports to that the same period, India exported $77.5 billion (Rs 6.8 lakh crore) worth of merchandise goods to the US and imported $42.2 billion (Rs 3.7 lakh crore) worth of goods from it, resulting in a trade surplus of $35.3 billion (Rs 3 lakh crore) in India's US is India's largest destination for pharma exports, accounting for over 31 per cent of the country's total pharmaceutical exports. As much as 47 per cent of all generics consumed in the US are imported from India. However, the Donald Trump administration's threat of imposition of a 25 per cent reciprocal tariff from August 1 (up from 0 to 6.7 per cent at present) has thrown the Indian pharma industry in a bind. Shares of Indian pharma companies, led by Sun Pharma, fell close to 6 per cent on the NSE (National Stock Exchange) on August 1 following president Trump's statements on the tariff imposition, and his letters to 17 top US pharma companies asking them to reduce their rates in line with what prevailed in other countries. Some fear Trump may send a similar letter to Sun Pharma, which earns as much as 20 per cent of its total revenues from the US Indian industry was hoping against hope that Trump would not hike tariffs on generic drugs since these are life-saving. However, Trump had indicated earlier this year too that tariffs on pharma products would be 25 per cent from April 2 onwards, without pinpointing any nation. He later gave a 90-day reprieve to countries, and the new deadline for the tariffs was put as August imports roughly $800 million worth of pharmaceutical products from the US, and imposes a tariff of 10 per cent. Experts say that even if higher tariffs are imposed on active pharma ingredients (APIs), which are raw materials going into pharma production, India could still be competitive, if tariffs on other API-supplying countries are higher than that of the US will still be dependent on countries like India since the cost of manufacturing certain drugs in the US would be at least six times compared to that of manufacturing the same product in India, say industry US market, which relies heavily on India for APIs and low-cost generics, would struggle to find alternatives, according to Namit Joshi, chairman of Pharmexcil (Pharmaceuticals Export Promotion Council of India). 'Efforts to shift pharmaceutical manufacturing and API production to other countries or within the US will take at least 3-5 years to establish meaningful capacity,' he was quoted in media reports. advertisement'There is no need for panic. The industry should lie low for now since the US has not yet increased the tariffs. Who else can give the US such competitively-priced goods in large quantities and high quality?' Daara Patel, secretary general of the Indian Drug Manufacturers Association, had said in an interview to INDIA TODAY in April. 'Even if it increases up to 10 per cent, the industry should be able to absorb it or pass it on to the US consumers. They would not mind paying for it since it all works on insurance money,' he what if the US decides to go for a higher tariff? 'In case the US raises tariffs beyond 15 per cent, India will have to look at newer markets in East Africa and the Middle East. These markets are neither high value nor high in volumes, but it will be a better option than dealing with an uncertain US market alone,' Patel had saidSubscribe to India Today Magazine- EndsTune InMust Watch

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store